These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16308271)

  • 1. Changes in serological biomarkers of liver function and connective tissue turnover in chronic hepatitis B during lamivudine therapy.
    Maxwell PR; Flisiak R
    Biomarkers; 2005; 10(6):475-84. PubMed ID: 16308271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of alpha-glutathione-S-transferase as a biomarker of lamivudine therapy for chronic hepatitis B.
    Maxwell PR; Flisiak R
    Dig Dis Sci; 2006 Oct; 51(10):1706-11. PubMed ID: 16983502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
    Liao Y; Gong J; Zhou W; Dong H; Liang J; Luo M; Hu B
    J Med Virol; 2019 Apr; 91(4):642-649. PubMed ID: 30537157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.
    Kweon YO; Goodman ZD; Dienstag JL; Schiff ER; Brown NA; Burchardt E; Schoonhoven R; Brenner DA; Fried MW
    J Hepatol; 2001 Dec; 35(6):749-55. PubMed ID: 11738102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
    van Zonneveld M; Zondervan PE; Cakaloglu Y; Simon C; Akarca US; So TM; Flink HJ; de Man RA; Schalm SW; Janssen HL;
    Liver Int; 2006 May; 26(4):399-405. PubMed ID: 16629642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus.
    Dong H; Xu C; Zhou W; Liao Y; Cao J; Li Z; Hu B
    Clin Chim Acta; 2018 Aug; 483():145-150. PubMed ID: 29709450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy.
    Park GJ; Katelaris PH; Jones DB; Seow F; Lin BP; Le Couteur DG; Ngu MC
    Aliment Pharmacol Ther; 2005 Sep; 22(5):395-403. PubMed ID: 16128677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
    Lai CL; Chien RN; Leung NW; Chang TT; Guan R; Tai DI; Ng KY; Wu PC; Dent JC; Barber J; Stephenson SL; Gray DF
    N Engl J Med; 1998 Jul; 339(2):61-8. PubMed ID: 9654535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients.
    Zubkin M; Balakirev E; Chervinko V; Baranova F; Zolotarevsky V; Bakulin I; Stahanova V; Stanke A; Stenina I; Kovalchuk A; Novozhenov V
    Int J Artif Organs; 2007 Apr; 30(4):308-14. PubMed ID: 17520567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine as initial treatment for chronic hepatitis B in the United States.
    Dienstag JL; Schiff ER; Wright TL; Perrillo RP; Hann HW; Goodman Z; Crowther L; Condreay LD; Woessner M; Rubin M; Brown NA
    N Engl J Med; 1999 Oct; 341(17):1256-63. PubMed ID: 10528035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased ratio of CD4/CD8 lymphocytes might be predictive for successful interferon alpha and lamivudine combined therapy in childhood chronic hepatitis B infection: A preliminary study.
    Genel F; Unal F; Ozgenc F; Aksu G; Aydogdu S; Kutukculer N; Yagci RV
    J Gastroenterol Hepatol; 2003 Jun; 18(6):645-50. PubMed ID: 12753145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B.
    Tatulli I; Francavilla R; Rizzo GL; Vinciguerra V; Ierardi E; Amoruso A; Panella C; Francavilla A
    J Hepatol; 2001 Dec; 35(6):805-10. PubMed ID: 11738109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concentration of Fas in the serum and liver tissue in viral chronic hepatitis B patients treated with lamivudine.
    Lapinski TW
    Hepatogastroenterology; 2005; 52(62):575-9. PubMed ID: 15816481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
    Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.
    Perrillo R; Hann HW; Mutimer D; Willems B; Leung N; Lee WM; Moorat A; Gardner S; Woessner M; Bourne E; Brosgart CL; Schiff E
    Gastroenterology; 2004 Jan; 126(1):81-90. PubMed ID: 14699490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B.
    Xu B; Zhou NM; Cao WT; Li XJ
    World J Gastroenterol; 2018 Oct; 24(37):4272-4280. PubMed ID: 30310260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.